Xenon Pharmaceuticals Inc.
XENE
$37.11
-$0.40-1.07%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -84.71M | -65.05M | -65.69M | -62.79M | -57.92M |
| Total Depreciation and Amortization | 632.00K | 659.00K | 633.00K | 669.00K | 641.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.22M | 14.93M | 8.48M | 11.89M | 16.34M |
| Change in Net Operating Assets | 2.62M | -12.19M | 2.19M | -911.00K | 9.80M |
| Cash from Operations | -64.23M | -61.65M | -54.39M | -51.15M | -31.15M |
| Capital Expenditure | -157.00K | -43.00K | -783.00K | -590.00K | -1.51M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 82.42M | 34.55M | 99.29M | 2.57M | 110.71M |
| Cash from Investing | 82.26M | 34.51M | 98.50M | 1.98M | 109.19M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 65.00K | 1.15M | 12.13M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 65.00K | 1.15M | 12.13M | -- | -- |
| Foreign Exchange rate Adjustments | 632.00K | -64.00K | -1.16M | 54.00K | -202.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.72M | -26.06M | 55.09M | -49.11M | 77.84M |